IRIS Accounts Production v26.1.10.61 05467946 director 1.1.25 31.12.25 31.12.25 false true false false false true false Ordinary shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh054679462024-12-31054679462025-12-31054679462025-01-012025-12-31054679462023-12-31054679462024-01-012024-12-31054679462024-12-3105467946ns15:EnglandWales2025-01-012025-12-3105467946ns14:PoundSterling2025-01-012025-12-3105467946ns10:Director12025-01-012025-12-3105467946ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3105467946ns10:SmallEntities2025-01-012025-12-3105467946ns10:AuditExempt-NoAccountantsReport2025-01-012025-12-3105467946ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3105467946ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3105467946ns10:FullAccounts2025-01-012025-12-310546794612025-01-012025-12-3105467946ns10:OrdinaryShareClass12025-01-012025-12-3105467946ns10:CompanySecretary12025-01-012025-12-3105467946ns10:RegisteredOffice2025-01-012025-12-3105467946ns5:CurrentFinancialInstruments2025-12-3105467946ns5:CurrentFinancialInstruments2024-12-3105467946ns5:Non-currentFinancialInstruments2025-12-3105467946ns5:Non-currentFinancialInstruments2024-12-3105467946ns5:ShareCapital2025-12-3105467946ns5:ShareCapital2024-12-3105467946ns5:SharePremium2025-12-3105467946ns5:SharePremium2024-12-3105467946ns5:RetainedEarningsAccumulatedLosses2025-12-3105467946ns5:RetainedEarningsAccumulatedLosses2024-12-3105467946ns5:PatentsTrademarksLicencesConcessionsSimilar2024-12-3105467946ns5:PatentsTrademarksLicencesConcessionsSimilar2025-01-012025-12-3105467946ns5:PatentsTrademarksLicencesConcessionsSimilar2025-12-3105467946ns5:PatentsTrademarksLicencesConcessionsSimilar2024-12-3105467946ns5:PlantMachinery2024-12-3105467946ns5:FurnitureFittings2024-12-3105467946ns5:MotorVehicles2024-12-3105467946ns5:ComputerEquipment2024-12-3105467946ns5:PlantMachinery2025-01-012025-12-3105467946ns5:FurnitureFittings2025-01-012025-12-3105467946ns5:MotorVehicles2025-01-012025-12-3105467946ns5:ComputerEquipment2025-01-012025-12-3105467946ns5:PlantMachinery2025-12-3105467946ns5:FurnitureFittings2025-12-3105467946ns5:MotorVehicles2025-12-3105467946ns5:ComputerEquipment2025-12-3105467946ns5:PlantMachinery2024-12-3105467946ns5:FurnitureFittings2024-12-3105467946ns5:MotorVehicles2024-12-3105467946ns5:ComputerEquipment2024-12-3105467946ns5:LeasedAssetsHeldAsLesseens5:PlantMachinery2024-12-3105467946ns5:LeasedAssetsHeldAsLesseens5:PlantMachinery2025-01-012025-12-3105467946ns5:LeasedAssetsHeldAsLesseens5:PlantMachinery2025-12-3105467946ns5:LeasedAssetsHeldAsLesseens5:PlantMachinery2024-12-3105467946ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3105467946ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3105467946ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-12-3105467946ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-12-3105467946ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2025-12-3105467946ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-12-3105467946ns5:HirePurchaseContractsns5:BetweenOneFiveYears2025-12-3105467946ns5:HirePurchaseContractsns5:BetweenOneFiveYears2024-12-3105467946ns5:HirePurchaseContracts2025-12-3105467946ns5:HirePurchaseContracts2024-12-3105467946ns5:WithinOneYear2025-12-3105467946ns5:WithinOneYear2024-12-3105467946ns5:BetweenOneFiveYears2025-12-3105467946ns5:BetweenOneFiveYears2024-12-3105467946ns5:AllPeriods2025-12-3105467946ns5:AllPeriods2024-12-3105467946ns5:DeferredTaxation2024-12-3105467946ns5:DeferredTaxation2025-01-012025-12-3105467946ns5:DeferredTaxation2025-12-3105467946ns10:OrdinaryShareClass12025-12-31
REGISTERED NUMBER: 05467946 (England and Wales)













Unaudited Financial Statements

for the Year Ended 31 December 2025

for

Implants International Limited

Implants International Limited (Registered number: 05467946)






Contents of the Financial Statements
for the Year Ended 31 December 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Implants International Limited

Company Information
for the Year Ended 31 December 2025







DIRECTOR: N Emmanuel





SECRETARY: N Emmanuel





REGISTERED OFFICE: 71 Jay Avenue
Teesside Industrial Estate
Thornaby On Tees
Cleveland
TS17 9LZ





REGISTERED NUMBER: 05467946 (England and Wales)





ACCOUNTANTS: Clive Owen LLP
Chartered Accountants
Great North House
Allington Way
DARLINGTON
Co Durham
DL1 4QB

Implants International Limited (Registered number: 05467946)

Balance Sheet
31 December 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 994,285 1,077,741
Tangible assets 5 831,262 821,206
1,825,547 1,898,947

CURRENT ASSETS
Stocks 6 1,385,285 1,361,285
Debtors 7 4,460,495 4,360,322
Cash at bank and in hand 12,341 24,066
5,858,121 5,745,673
CREDITORS
Amounts falling due within one year 8 347,869 437,302
NET CURRENT ASSETS 5,510,252 5,308,371
TOTAL ASSETS LESS CURRENT
LIABILITIES

7,335,799

7,207,318

CREDITORS
Amounts falling due after more than one
year

9

(2,657,034

)

(2,639,946

)

PROVISIONS FOR LIABILITIES 11 (381,046 ) (320,445 )
NET ASSETS 4,297,719 4,246,927

CAPITAL AND RESERVES
Called up share capital 12 216,223 216,223
Share premium 2,994,976 2,994,976
Retained earnings 1,086,520 1,035,728
SHAREHOLDERS' FUNDS 4,297,719 4,246,927

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Implants International Limited (Registered number: 05467946)

Balance Sheet - continued
31 December 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 9 June 2026 and were signed by:





N Emmanuel - Director


Implants International Limited (Registered number: 05467946)

Notes to the Financial Statements
for the Year Ended 31 December 2025

1. STATUTORY INFORMATION

Implants International Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

There were no material departures from that standard.

The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.

Turnover
Turnover is measured at the fair value of the consideration receivable, excluding discounts, rebates, value added tax and other sales taxes.

Income Recognition
Income is recognised when a contract for the sale of goods is determined as unconditional.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
Basic financial instruments are recognised at amortised cost with changes recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Implants International Limited (Registered number: 05467946)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 10% on cost
Fixtures and fittings - 25% on cost
Computer Equipment - 33.33% on cost

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of nil years.

Grants receivable
Revenue based grants are credited to the profit and loss account. Capital based grants are credited to the profit and loss account, in equal instalments, over the estimated useful life of the related asset.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 18 (2024 - 10 ) .

Implants International Limited (Registered number: 05467946)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

4. INTANGIBLE FIXED ASSETS
Patents
and
licences
£   
COST
At 1 January 2025 1,321,379
Additions 105,533
At 31 December 2025 1,426,912
AMORTISATION
At 1 January 2025 243,638
Amortisation for year 188,989
At 31 December 2025 432,627
NET BOOK VALUE
At 31 December 2025 994,285
At 31 December 2024 1,077,741

5. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Surgical Computer
machinery fittings Equipment equipment Totals
£    £    £    £    £   
COST
At 1 January 2025 642,024 11,060 578,500 11,210 1,242,794
Additions 69,475 836 - 475 70,786
At 31 December 2025 711,499 11,896 578,500 11,685 1,313,580
DEPRECIATION
At 1 January 2025 404,077 9,429 - 8,082 421,588
Charge for year 57,062 1,459 - 2,209 60,730
At 31 December 2025 461,139 10,888 - 10,291 482,318
NET BOOK VALUE
At 31 December 2025 250,360 1,008 578,500 1,394 831,262
At 31 December 2024 237,947 1,631 578,500 3,128 821,206

Implants International Limited (Registered number: 05467946)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

5. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Plant and
machinery
£   
COST
At 1 January 2025
and 31 December 2025 149,950
DEPRECIATION
At 1 January 2025 15,406
Charge for year 14,995
At 31 December 2025 30,401
NET BOOK VALUE
At 31 December 2025 119,549
At 31 December 2024 134,544

6. STOCKS
2025 2024
£    £   
Stocks 1,385,285 1,361,285

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 4,408,769 4,313,312
Other debtors 22,039 27,308
Prepayments and accrued income 29,687 19,702
4,460,495 4,360,322

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 24,516 21,183
Hire purchase contracts (see note 10) 35,062 23,969
Trade creditors 169,099 263,796
Taxation and social security 38,168 85,318
Other creditors 72,093 37,349
Accruals and deferred income 8,931 5,687
347,869 437,302

Implants International Limited (Registered number: 05467946)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Bank loans - 1-2 years 270,211 275,194
Hire purchase contracts (see note 10) 73,856 90,400
Directors' loan accounts 2,312,967 2,274,352
2,657,034 2,639,946

10. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase
contracts
2025 2024
£    £   
Net obligations repayable:
Within one year 35,062 23,969
Between one and five years 73,856 90,400
108,918 114,369

Non-cancellable
operating leases
2025 2024
£    £   
Within one year 78,590 78,590
Between one and five years 275,065 353,655
353,655 432,245

11. PROVISIONS FOR LIABILITIES
2025 2024
£    £   
Deferred tax 200,046 210,445
Other provisions 181,000 110,000
381,046 320,445

Deferred
tax
£   
Balance at 1 January 2025 210,445
Provided during year (10,399 )
Balance at 31 December 2025 200,046

Implants International Limited (Registered number: 05467946)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

12. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
216,223 Ordinary shares 1 216,223 216,223